Research Paper Volume 13, Issue 6 pp 8026—8039

mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction


Figure 5. Serum levels of fluorescent hydroxynonenal- (HNE, A) and malondialdehyde- (MDA, B) protein adducts in patients treated with calcineurin inhibitor (CNi) or CNi + mTOR inhibitor (CNi+mTORi). AUF, arbitrary units of fluorescence.